On September 19, 2025 (local time in the U.S.), during the 919 Futurist Day & Investor Community Day event held at its Los Angeles headquarters, Faraday Future (FFAI) declared a strategic investment of roughly US$41 million in Qualigen Therapeutics, Inc. (QLGN), a company listed on NASDAQ. This investment aims to bolster QLGN's shift into the crypto and Web3 ecosystem.

As per the agreement, Faraday Future will contribute about US$30 million, which will enable it to acquire approximately 55% of QLGN's shares. Jia Yueting, the founder and co - CEO of Faraday Future, will make a personal investment of around US$4 million through an FFGP loan. He has also committed to a two - year lock - up period.

Once the transaction is finalized, both Faraday Future and Jia Yueting will jointly hold approximately 62% of QLGN's shares. QLGN has plans to rebrand itself as CXC10. It will concentrate on "three major growth engines" with the ambition of becoming a prominent listed company in the United States that seamlessly integrates Web2 and Web3, along with AI and crypto.

Faraday Future mentioned that this investment, coupled with product innovation, will expedite the implementation of the company's "Dual Flywheel and Dual Bridge" ecosystem strategy, thereby further boosting shareholder value.